On the basis of these findings, we performed a systematic review and meta-analysis in order to fully understand the diagnostic performance of uKIM-1 and serum/plasma YKL-40 for predicting early diabetic nephropathy in patients with type 2 diabetes. Here, CHI3L1 is linked to diabetic kidney disease.